Positron Emission Tomography (PET) News and Research RSS Feed - Positron Emission Tomography (PET) News and Research

Biochemical compound demonstrates increasing potential for use in cancer imaging

Biochemical compound demonstrates increasing potential for use in cancer imaging

In the paper, an international team reviewed studies conducted over the past 30 years on a particular tracer, called “18F-FLT,” and found that it has the potential to improve diagnostic imaging, and thus treatment, of some cancers. [More]
Lilly, Roche Diagnostics partner to develop cerebrospinal fluid assay for amyloid-beta 1-42

Lilly, Roche Diagnostics partner to develop cerebrospinal fluid assay for amyloid-beta 1-42

Eli Lilly and Company today announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42. [More]
TSRI scientists receive $2.1 million NIH grant to create new library of drug candidates

TSRI scientists receive $2.1 million NIH grant to create new library of drug candidates

Scientists at The Scripps Research Institute have received a grant of more than $2.1 million from the National Institutes of Health's National Institute of General Medical Sciences to create and screen a new library of drug candidates. [More]
JGU employs new particle accelerator to enhance research into radiopharmaceutical chemistry

JGU employs new particle accelerator to enhance research into radiopharmaceutical chemistry

A new particle accelerator will further enhance the research landscape at Johannes Gutenberg University Mainz. It is to be employed to conduct research into potential applications of medical relevance. [More]
Feeling sad can alter levels of inflammatory proteins linked to increased risk of comorbid diseases

Feeling sad can alter levels of inflammatory proteins linked to increased risk of comorbid diseases

Feeling sad can alter levels of stress-related opioids in the brain and increase levels of inflammatory proteins in the blood that are linked to increased risk of comorbid diseases including heart disease, stroke and metabolic syndrome, according to a study by researchers at The University of Texas Health Science Center at Houston. [More]
NeuroQuest to start U.S. clinical validation trials of blood test for early diagnosis of Alzheimer's disease

NeuroQuest to start U.S. clinical validation trials of blood test for early diagnosis of Alzheimer's disease

NeuroQuest Development Center, Inc., today announced they have entered into a service agreement with the University of California, San Diego for collection and processing of blood samples for their U.S. clinical validation trials. [More]
Zecotek Photonics receives order for patented LFS scintillation crystals

Zecotek Photonics receives order for patented LFS scintillation crystals

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, is pleased to announce that it has received an order for its patented Lutetium Fine Silicate (LFS) scintillation crystals from a specialized medical imaging device manufacturer based in the United States. [More]
Lawson scientists develop commercial imaging product for PET/MRI scanners

Lawson scientists develop commercial imaging product for PET/MRI scanners

Scientists at Lawson Health Research Institute, in collaboration with Ceresensa Inc., have produced the first commercial imaging product available in the world for PET/MRI scanners. The novel PET-transparent MRI head coil provides unparalleled images to advance the study, diagnosis and treatment of a wide range of diseases. [More]
New nanocarriers may effectively deliver therapeutic drug to GBM tumors

New nanocarriers may effectively deliver therapeutic drug to GBM tumors

Glioblastoma multiforme, a cancer of the brain also known as "octopus tumors" because of the manner in which the cancer cells extend their tendrils into surrounding tissue, is virtually inoperable, resistant to therapies, and always fatal, usually within 15 months of onset. [More]
Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

Dementia specialists and PET imaging providers can now register to participate in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study at Ideas-Study.org. [More]
University of Manchester scientists identify brain mechanism that raises pain threshold

University of Manchester scientists identify brain mechanism that raises pain threshold

Scientists at The University of Manchester have shown for the first time that the numbers of opiate receptors in the brain increases to combat severe pain in arthritis sufferers. [More]
Berkeley Lab researchers set out to help develop world's first total-body PET scanner

Berkeley Lab researchers set out to help develop world's first total-body PET scanner

Scientists from the Department of Energy's Lawrence Berkeley National Laboratory have set out to help build the world's first total-body positron emission tomography (PET) scanner, a medical imaging device that could change the way cancers and other diseases are diagnosed and treated. [More]
New clinical study focuses on investigational treatment to reduce impact of key protein from the brain

New clinical study focuses on investigational treatment to reduce impact of key protein from the brain

The Nantz National Alzheimer Center at Houston Methodist Hospital is part of a landmark clinical trial that looks at removing a key protein from the brain to prevent memory loss at least a decade before symptoms are noticed in healthy older adults. [More]
UC Davis researchers awarded $15.5 million to develop world's first total-body PET scanner

UC Davis researchers awarded $15.5 million to develop world's first total-body PET scanner

A UC Davis research team has been awarded $15.5 million to build the world's first total-body positron emission tomography (PET) scanner, which could fundamentally change the way cancers are tracked and treated and put the university on the nation's leading edge of molecular imaging. [More]
Seno completes PIONEER Pivotal Study of non-invasive Imagio breast imaging system

Seno completes PIONEER Pivotal Study of non-invasive Imagio breast imaging system

Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, announced today it has completed the final phase of the company's U.S.-based PIONEER Pivotal Study of the Imagio® breast imaging system. [More]
Novel radiopharmaceutical probe has potential to save lives of patients with ischemic stroke

Novel radiopharmaceutical probe has potential to save lives of patients with ischemic stroke

A novel radiopharmaceutical probe developed at Massachusetts General Hospital has the potential of providing physicians with information that could save the lives of patients with ischemic stroke or pulmonary embolism - conditions caused when important blood vessels are blocked by a clot that has traveled from another part of the body. [More]
PET imaging technique does not improve outcomes in esophageal cancer patients

PET imaging technique does not improve outcomes in esophageal cancer patients

Patients with cancer of the esophagus—also known as the gullet—are often given chemo- or radiotherapy, with the aim of shrinking the tumor before it is surgically removed. [More]
Dementia brain imaging is helpful but not definitive, shows new research

Dementia brain imaging is helpful but not definitive, shows new research

MRI scans and other tools to detect and diagnose dementia are helpful but not definitive - according to new research from the University of East Anglia. [More]
Patients undergoing surgery for lung cancer wait too long to receive treatment, skip vital diagnostic steps

Patients undergoing surgery for lung cancer wait too long to receive treatment, skip vital diagnostic steps

Patients undergoing surgery for lung cancer may wait too long to receive treatment, and too many patients skip vital diagnostic steps that are needed to help determine the best possible treatment, according to an article in the August 2015 issue of The Annals of Thoracic Surgery. [More]
Study looks at impact of amyloid imaging on diagnosis, management of patients with cognitive impairment

Study looks at impact of amyloid imaging on diagnosis, management of patients with cognitive impairment

Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced new data showing that knowledge of amyloid status as determined by Florbetapir F 18 Injection imaging altered diagnosis and management in the majority of patients being studied. [More]
Advertisement